Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

BACKGROUND: The COVID-19 pandemic continues to pose a significant worldwide threat to human health, as emerging SARS-CoV-2 Omicron variants exhibit resistance to therapeutic antibodies and the ability to evade vaccination-induced antibodies. Here, we aimed to identify human antibodies (hAbs) from co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Hsiao-Ling, Liang, Kang-Hao, Lu, Ruei-Min, Kuo, Ting-Wen, Lin, Yi‑Ling, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388472/
https://www.ncbi.nlm.nih.gov/pubmed/37525188
http://dx.doi.org/10.1186/s12929-023-00955-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388472/
https://www.ncbi.nlm.nih.gov/pubmed/37525188
http://dx.doi.org/10.1186/s12929-023-00955-x

Ejemplares similares